FFG
TMO icon

Fortem Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Fortem Financial Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-680
Closed -$402K – 203
2022
Q1 		$402K Sell
680
-411
-38% -$236K 0.18% 122
2021
Q4 		$728K Sell
1,091
-79
-7% -$49.3K 0.33% 98
2021
Q3 		$668K Sell
1,170
-126
-10% -$69.2K 0.34% 99
2021
Q2 		$654K Buy
1,296
+33
+3% +$15.6K 0.33% 98
2021
Q1 		$576K Sell
1,263
-63
-5% -$30.1K 0.33% 92
2020
Q4 		$618K Hold
1,326
– – 0.37% 85
2020
Q3 		$585K Sell
1,326
-2,256
-63% -$932K 0.42% 82
2020
Q2 		$1.3M Sell
3,582
-209
-6% -$70.1K 1% 32
2020
Q1 		$1.07M Sell
3,791
-2,205
-37% -$695K 0.98% 30
2019
Q4 		$1.95M Sell
5,996
-690
-10% -$209K 1.44% 18
2019
Q3 		$1.95M Sell
6,686
-1,071
-14% -$307K 1.66% 16
2019
Q2 		$2.28M Sell
7,757
-327
-4% -$90.1K 2.29% 4
2019
Q1 		$2.21M Buy
8,084
+124
+2% +$30.9K 2.3% 5
2018
Q4 		$1.78M Buy
+7,960
New +$1.87M 2.15% 8

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fortem Financial Group's TMO Position: Q2 2022 in Review

Fortem Financial Group sold out of Thermo Fisher Scientific (TMO) in Q2 2022, closing a stake of 680 shares — an estimated $402K sold.

Fortem Financial Group first reported a position in TMO in Q4 2018 and held it in 14 quarters. The position peaked at $2.28M in Q2 2019. 2,281 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

  • Fortem Financial Group reported no remaining Thermo Fisher Scientific position as of Q2 2022 after selling out during the quarter.
  • Fortem Financial Group sold 680 Thermo Fisher Scientific shares in Q2 2022, an estimated $402K.
  • Fortem Financial Group first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 14 quarters.
  • Fortem Financial Group's Thermo Fisher Scientific position peaked at $2.28M in Q2 2019.
  • 2,281 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Fortem Financial Group's 13F filing for Q2 2022, filed 25 Jul 2022.